MA44264A - ORAL PHARMACEUTICAL COMPOSITION OF ISOTRETINOIN - Google Patents

ORAL PHARMACEUTICAL COMPOSITION OF ISOTRETINOIN

Info

Publication number
MA44264A
MA44264A MA044264A MA44264A MA44264A MA 44264 A MA44264 A MA 44264A MA 044264 A MA044264 A MA 044264A MA 44264 A MA44264 A MA 44264A MA 44264 A MA44264 A MA 44264A
Authority
MA
Morocco
Prior art keywords
isotretinoin
pharmaceutical composition
oral pharmaceutical
oral
composition
Prior art date
Application number
MA044264A
Other languages
French (fr)
Inventor
Pankaj Prabhakar AMRUTKAR
Subodh Deshmukh
Ravi Kochhar
Sumit Madan
Original Assignee
Sun Pharmaceutical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sun Pharmaceutical Ind Ltd filed Critical Sun Pharmaceutical Ind Ltd
Priority to MA044264A priority Critical patent/MA44264A/en
Publication of MA44264A publication Critical patent/MA44264A/en

Links

MA044264A 2015-05-29 2015-05-29 ORAL PHARMACEUTICAL COMPOSITION OF ISOTRETINOIN MA44264A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MA044264A MA44264A (en) 2015-05-29 2015-05-29 ORAL PHARMACEUTICAL COMPOSITION OF ISOTRETINOIN

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MA044264A MA44264A (en) 2015-05-29 2015-05-29 ORAL PHARMACEUTICAL COMPOSITION OF ISOTRETINOIN

Publications (1)

Publication Number Publication Date
MA44264A true MA44264A (en) 2019-01-09

Family

ID=77520379

Family Applications (1)

Application Number Title Priority Date Filing Date
MA044264A MA44264A (en) 2015-05-29 2015-05-29 ORAL PHARMACEUTICAL COMPOSITION OF ISOTRETINOIN

Country Status (1)

Country Link
MA (1) MA44264A (en)

Similar Documents

Publication Publication Date Title
DK3529248T3 (en) Pharmaceutical compositions
MA41265A (en) COMPOSITIONS FOR THE ADMINISTRATION OF ILÉO-JEJUNAL DRUGS.
DK3297605T3 (en) TOPIC, PHARMACEUTICAL COMPOSITIONS
DK3116491T3 (en) PHARMACEUTICAL COMPOSITIONS OF THERAPEUTIC ACTIVE COMPOUNDS
MA50541A (en) PHARMACEUTICAL FORMULATIONS
MA47816A (en) PHARMACEUTICAL COMPOSITION CONSISTING OF SELEXIPAG
DK3532029T3 (en) Liquid pharmaceutical composition
DK3529240T3 (en) Pharmaceutical compounds
MA46867A (en) PHARMACEUTICAL FORMULATIONS
MA42303A (en) PHARMACEUTICAL FORMULATIONS
FR3022462B1 (en) ORAL COMPOSITION OF ANTI-TNFALPHA ANTIBODY
DK3709978T3 (en) Pharmaceutical oral formulation comprising bacteria
MA43705A (en) PHARMACEUTICAL FORMULATION
DK3634377T3 (en) Pharmaceutical formulation
MA40781A (en) PHARMACEUTICAL COMPOSITION OF LOW DOSAGE ISOTRETINOIN FOR ORAL USE
DK3821905T3 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING INSULIN
MA47516A (en) PHARMACEUTICAL COMPOSITION
DK3278801T3 (en) PHARMACEUTICAL COMPOSITION CONTAINING MIRROR BACKGROUND
MA49837A (en) PHARMACEUTICAL COMPOSITIONS
DK3544584T3 (en) PHARMACEUTICAL PARENTERAL FORMULATION CONTAINING CARGLUMIC ACID
MA45158A (en) PHARMACEUTICAL COMPOSITION CONSISTING OF ÉTEPLIRSEN
DK3280447T3 (en) PHARMACEUTICAL FORMULATIONS
DK3672631T3 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING ANTI-BETA-AMYLOID ANTIBODIES
EP3302438A4 (en) Oral pharmaceutical composition of isotretinoin
DK3601277T3 (en) PHARMACEUTICAL FORMULATION